A detailed history of Wealth Effects LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Effects LLC holds 15,077 shares of BMY stock, worth $840,844. This represents 0.31% of its overall portfolio holdings.

Number of Shares
15,077
Previous 10,927 37.98%
Holding current value
$840,844
Previous $453,000 72.19%
% of portfolio
0.31%
Previous 0.19%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$39.66 - $51.75 $164,589 - $214,762
4,150 Added 37.98%
15,077 $780,000
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $10,424 - $13,724
-259 Reduced 2.32%
10,927 $453,000
Q1 2024

Apr 22, 2024

SELL
$47.98 - $54.4 $767,200 - $869,856
-15,990 Reduced 58.84%
11,186 $606,000
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $745,186 - $889,212
15,371 Added 130.21%
27,176 $1.39 Million
Q3 2023

Oct 16, 2023

SELL
$57.89 - $64.73 $72,246 - $80,783
-1,248 Reduced 9.56%
11,805 $685,000
Q2 2023

Jul 18, 2023

SELL
$63.71 - $70.74 $6,944 - $7,710
-109 Reduced 0.83%
13,053 $834,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $10,776 - $12,222
-164 Reduced 1.23%
13,162 $912,000
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $116,347 - $137,771
-1,699 Reduced 11.31%
13,326 $958,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $0 - $76
1 Added 0.01%
15,025 $1.07 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $34,674 - $41,578
-564 Reduced 3.62%
15,024 $1.1 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $835,984 - $974,561
15,588 New
15,588 $972,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.